Immunofluorescence experiments revealed heightened MAP7 protein expression in ovarian cancer A2780-DDP cells, predominantly localized to the nucleus (Fig. 6A), indicating nuclear MAP7's key role in cisplatin resistance. The gene discussed is MAP7; the disease is ovarian carcinoma.